Update on "open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder".
Moroz
G
G
Magni
G
G
Fava
M
M
D001577:Benzophenones / Q000009:adverse effects / Q000627:therapeutic use*; D065098:Catechol O-Methyltransferase Inhibitors; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009596:Nitrophenols; D000077867:Tolcapone
D001577:Benzophenones; D065098:Catechol O-Methyltransferase Inhibitors; D004791:Enzyme Inhibitors; D009596:Nitrophenols; D000077867:Tolcapone